Physician profile
Joseph Barr
NPI 1447292503
$1,868.85
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $657 · 2021: $513 · 2022: $142.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $394.11 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $302.44 | 2019-2021 | |
| Astellas Pharma US INC | $257.64 | 2019-2021 | |
| Novo Nordisk INC | $209.01 | 2019-2021 | |
| Lilly USA, LLC | $193.18 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $63.48 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $60.31 | 2019-2020 | |
| Amarin Pharma, INC. | $58.33 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.59 | 2020-2021 | |
| Abbvie INC. | $51.87 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.18 | 2019-2021 | |
| Pfizer INC. | $39.13 | 2019-2021 | |
| Horizon Therapeutics Plc | $36.78 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.53 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.92 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.91 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.96 | 2019 | |
| Glaxosmithkline, LLC. | $13.85 | 2021 | |
| Medtronic, INC. | $12.63 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.